Skip to content

Use of Virtual Reality Mask or Music Therapy for Analgesia and Anxiolytic Purpose When Totally IVAD for Chemotherapy Under Local Anesthesia

Use of Virtual Reality Mask or Music Therapy for Analgesia and Anxiolytic Purpose When Totally Implanted Venous Access Device (IVAD) for Chemotherapy Under Local Anesthesia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04804735
Acronym
REVCCI
Enrollment
127
Registered
2021-03-18
Start date
2022-12-06
Completion date
2023-08-16
Last updated
2025-07-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Implanted Venous Access Device

Brief summary

Evaluate 2 medical devices on pain average and/or anxiety average in the totally Implanted Venous Access Device (IVAD) procedure under local anesthesia.

Detailed description

Evaluate the efficacy of virtual reality and music therapy on pain average and/or anxiety average in the totally Implanted Venous Access Device (IVAD) procedure under local anesthesia.

Interventions

DEVICEREV : local anesthesia and virtual reality

REV : local anesthesia and virtual reality in Implanted Venous Access Device (IVAD) procedure under local anesthesia

DEVICEMUS : local anesthesia and music therapy

MUS : local anesthesia and music therapy in Implanted Venous Access Device (IVAD) procedure under local anesthesia

Sponsors

Institut Curie
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

1. Patient aged between 18 and 85 years. 2. Patient with cancer care and having a totally Implanted Venous Access Device (IVAD) procedure under local anesthesia for chemotherapy. 3. Absence of anxiolytic premedication. 4. Patient affiliated to social insurance. 5. Absence of contra-indication to the use of virtual reality, music therapy instrument or local lidocaine anesthesia. 6. Signed informed consent form.

Exclusion criteria

1. Patient already participated to this study. 2. Patient deprived of liberty or under legal representative or under curatorship. 3. Psychiatric disease enabling communication. 4. Deafness or visual impairement. 5. Patient under beta-blockers medication. 6. Chronic pain present and not equilibrated before the measured procedure as \> 3 by the NRS. 7. Tracheotomy. 8. Low cervical tumor, or bilateral low cervical adenopathies. 9. Compression or jugular stenosis (uni or bilateral). 10. Jugular or subclavian thrombosis. 11. Patient under anticoagulants medication or having hesmostasis troubles. 12. Claustrophobia or thalassophobia inducing the possibility of rejecting the virtual reality mask or music therapy mask. 13. Patients not speaking french. 14. Pregnant and breastfeeding women.

Design outcomes

Primary

MeasureTime frameDescription
mean of pain felt during the whole IVAD procedure1 daypain means will be measured with the Numerical Rating Scale (NRS) from 0 to 10 with 0 corresponding to no pain and 10 the maximum pain feeling.
mean of anxiety felt during the whole IVAD procedure1 dayAnxiety means will be measured with the Numerical Rating Scale (NRS) from 0 to 10 with 0 corresponding to no anxiety and 10 the maximum anxiety feeling.

Secondary

MeasureTime frameDescription
Global patient satisfaction of NRS and comparison between the 3 groups.1 daypatient satisfaction of NRS
Correlation coefficient between the ANI air under the curve and the pain measure with the numerical rating scale.1 dayCorrelation coefficient between the ANI air under the curve and the pain measure with the numerical rating scale.
Anxiety NRS means felt during the procedure and comparison.1 dayNRS means
Pain NRS means felt during the procedure and comparison.1 dayNRS means
Tolerance evaluated by NRS and responses to the closed questions (dizziness, nausea, suffocating feeling) completed at the end of the procedure.1 dayNRS and responses to the closed questions

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 9, 2026